Regulators protecting patients in the news The FDA issued a warning letter to Intas Pharmaceuticals in March 2026, citing serious manufacturing violations, including inadequate investigations into failing drug quality results and significant data integrity lapses in electronic batch records, rendering products potentially adulterated
The Bottom Line The LBM LBM GLP 1 Nano Microneedle Patch claims to deliver prescription-level weight-loss medication via a patchwithout medical oversight
Differential acute phase immune responses by Angus and Romosinuano steers following an endotoxin challenge
Research from National Library of Medicine in 2024 also suggests GLP-1 drugs are linked to adverse gastrointestinal events, including nausea, vomiting, delayed gastric emptying and pancreatitis
RELATED QUESTIONS where to get tonga ali Sources: Andrew Huberman suggests looking for sources of Indonesian Tongkat Ali in particular, which is known for being potent in its effects on libido
Emerging Adulthood
